Glycans are involved in a plethora of human pathologies including infectious diseases. Especially, glycosaminoglycans (GAGs), like heparan sulfate and chondroitin sulfate, have been found to be involved in different crucial stages of microbial invasion. Here, we review various therapeutic approaches, which target the interface of host GAGs and microbial proteins and discuss their limitations and challenges for drug development.
Therapeutic strategies to target microbial protein–glycosaminoglycan interactions
Johannes Almer, Bernd Gesslbauer, Andreas J. Kungl; Therapeutic strategies to target microbial protein–glycosaminoglycan interactions. Biochem Soc Trans 17 December 2018; 46 (6): 1505–1515. doi: https://doi.org/10.1042/BST20170485
Download citation file: